IT|EN
Linkedin
Projects · NefroCenter Research

Our research projects

Clinical trials, observational studies, academic collaborations and initiatives supported by public and private bodies. Explore all active research lines across NefroCenter centres.

× Reset
16 projects · filter active

SAGE-IT

Smart Aging and New Health Technologies for Italy

SAGE-It develops an integrated ecosystem to support active and healthy ageing among older adults. The project combines technology validation, regional networks and skills development to accelerate the adoption of innovative solutions.

Ongoing dal 2026 Nephrology and Dialysis →

SISTEM

Sarcopenic syndrome with multimorbidity: prevention and management of chronic disease with naturally derived bioactive molecules of synergistic action.

SISTEM develops natural bioactive compounds for the prevention and treatment of sarcopenia through eco-sustainable approaches and personalised-medicine models.

Ongoing 2024–2027 Diabetology and its complications · Nutraceutics +1 →

AI-MEDICARD

Artificial Intelligence for MEDicine for Diabetes, Cardiology and Renal Disease – CARDiovascular Risk Prediction.

AI-MEDICARD is a Research project aimed at developing an integrated Artificial-Intelligence platform for the prediction of cardiovascular risk in patients with type 2 Diabetes Mellitus (T2DM). Scientific studies demonstrate a strong genetic susceptibility correlated with the increased risk of acute cardiovascular events in 9 subgroups of diabetic patients.

Ongoing 2024–2026 Cardiology · Diabetology and its complications +1 →

RENALERT-AI

Renal Dysfunction and Effects on Neurological and Attention-Related Tasks: the Role of Artificial Intelligence.

RENALERT-AI aims to develop an AI platform for the early prediction of cognitive decline in renal and haemodialysis patients, with the aim of supporting clinical practice through innovative tools for telemedicine, remote monitoring and predictive medicine

Ongoing 2024–2027 Cognitive decline · Nephrology and Dialysis →

SIATE

An Artificial-Intelligence-based clinical decision-support system for the personalisation of haemodialysis therapy.<br/>LONG DESCRIPTION → project_long_description · 9 segmenti

An Artificial-Intelligence-based clinical decision-support system for the personalisation of haemodialysis therapy, aimed at improving monitoring, therapeutic efficacy and patients' quality of life.

Ongoing 2024–2027 Nephrology and Dialysis →

ARKETIPO

Artificial Intelligence for the Early Diagnosis of Heart Failure through the Joint Analysis of Epigenetic and Clinical Markers.

AI systems for the early diagnosis of heart failure in diabetic and dialysis patients, combining personalised-medicine approaches through innovative epigenetic and clinical biomarkers.

Ongoing 2023–2026 Cardiology · Diabetology and its complications →

BRAIN CENTER

Multidisciplinary neurological research center

Multidisciplinary neurological research center focused on neurodegenerative diseases.

Ongoing Cognitive decline →

RiOSM

Research and Treatment Center for Obesity and Metabolic Syndrome

RiOSM envisages the creation of a multidisciplinary specialist Centre for the advanced management of patients with severe obesity and metabolic syndrome.

Ongoing 2026–2028 Diabetology and its complications · Metabolic syndrome and obesity +1 →

IBS-K

Irritable bowel syndrome and colorectal cancer risk: a predictive algorithm.

A prospective observational study dedicated to the early identification of patients with irritable bowel syndrome at risk of colorectal cancer, using clinical data, questionnaires and predictive algorithms to support personalised diagnostic pathways.

Ongoing dal 2023 Diabetology and its complications →

L-FABP-NC

Urinary Liver-Fatty Acid Binding Protein (L-FABP): assessment of a urinary biomarker predictive of the development of chronic kidney disease (CKD) in at-risk populations

A prospective study on the role of the urinary protein L-FABP as an early biomarker of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus.<br/>The project integrates clinical data and machine-learning algorithms to stratify renal and cardiovascular risk.

Ongoing dal 2022 Diabetology and its complications →

LH-COM

Evolution of cutaneous lipohypertrophies from insulin injection in type 1 and type 2 diabetic patients, with and without nephropathy.

A multi-year study on cutaneous lipohypertrophies from insulin injection in diabetic patients.<br/>The project assesses frequency, causes, clinical complications and the impact of structured education on correct injection technique.

Ongoing dal 2024 Diabetology and its complications →

STADICHOL

Ricerca delle cause di non aderenza alla terapia con statine in soggetti con diabete mellito tipo 2, sindrome metabolica e ipercolesterolemia moderata

Studio sull’aderenza alla terapia con statine in diabetici di tipo 2 (DM2), sindrome metabolica (SM) e ipercolesterolemia moderata (HM). Il progetto sviluppa modelli predittivi precoci per intercettare il rischio di non aderenza alla terapia e aumento di eventi cardiovascolari.

Ongoing 2025–2028 Diabetology and its complications · Nutraceutics →